Source comparison
MK-677 vs Direct GH Administration — Mechanistic Differences
Exogenous growth hormone administration (recombinant human GH injections) suppresses endogenous GH production through negative feedback on the hypothalamic-pituitary axis. Elevated serum GH levels signal the hypothalamus to reduce GH-releasing hormone (GHRH) s
This comparison does not assign a generated winner or score.
- Exogenous growth hormone administration (recombinant human GH injections) suppresses endogenous GH production through negative feedback on the hypothalamic-pituitary axis. Elevated serum GH levels signal the hypothalamus to reduce GH-releasing hormone (GHRH) secretion and increase somatostatin release, which inhibits further pituitary GH output. This is why patients on therapeutic GH replacement experience suppressed natural GH pulsatility and require continuous exogenous dosing to maintain serum levels.
- MK-677 operates through an entirely different mechanism. By acting as a ghrelin receptor agonist, it mimics the natural signal that tells the pituitary to release GH. It doesn't replace the hormone itself. The result is amplified pulsatile secretion without negative feedback suppression. Studies confirm that MK-677 increases both GH pulse amplitude and frequency while preserving the natural circadian rhythm of GH secretion, which peaks during slow-wave sleep.
- Mode of Action
- Direct hormone replacement. Bypasses natural signaling
- Receptor agonist. Amplifies endogenous pulsatility
- MK-677 preserves natural rhythm; GH does not
- Bioavailability
- Requires injection (SC/IM). Not orally active
- 60–70% oral bioavailability
- MK-677 allows oral dosing without injection
- Endogenous Suppression
- Suppresses natural GH production via negative feedback
- No suppression. Enhances natural pulse amplitude
- MK-677 works with the body; GH overrides it
- Dosing Frequency
- Daily or every-other-day injections
- Once daily oral dose
- MK-677 requires less frequent administration
- IGF-1 Response
- Direct elevation proportional to dose
- Indirect elevation via endogenous GH secretion
- Both elevate IGF-1, but through different pathways
- Professional Assessment
- GH replacement is appropriate for diagnosed deficiency; MK-677 is a research tool for studying GH dynamics without shutting down natural production. Fundamentally different clinical and research applications
- The distinction matters for research design. If a study aims to examine natural GH pulsatility under enhanced conditions, MK-677 is the appropriate tool. If the goal is to bypass endogenous production entirely, exogenous GH is required. They are not interchangeable.